SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-09-000246
Filing Date
2009-05-08
Accepted
2009-05-08 15:56:40
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a52400e10vq.htm 10-Q 414099
2 EX-10.1 a52400exv10w1.htm EX-10.1 132758
3 EX-31.1 a52400exv31w1.htm EX-31.1 6780
4 EX-31.2 a52400exv31w2.htm EX-31.2 6794
5 EX-32.1 a52400exv32w1.htm EX-32.1 3569
  Complete submission text file 0000936392-09-000246.txt   565628
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 09810620
SIC: 2834 Pharmaceutical Preparations